Mammographic density is related to stroma and stromal proteoglycan expression

Breast Cancer Research

Volumn 5, Issue 5, 2003, Pages

  Alowami, Salem ^a   Troup, Sandra ^b   Al Haddad, Sahar ^b   Kirkpatrick, Iain ^c   Watson, Peter H ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c HEALTH SCIENCES CENTRE   (Canada)

Author keywords

decorin; density; lumican; mammography; stroma

Indexed keywords

DECORIN; KERATAN SULFATE; LUMICAN; PROTEOCHONDROITIN SULFATE; PROTEOGLYCAN; SCLEROPROTEIN;

AGED; ARTICLE; BIOSYNTHESIS; BREAST; BREAST TUMOR; CARCINOMA IN SITU; CHEMISTRY; CLASSIFICATION; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; HUMAN; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MAMMOGRAPHY; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PAGET NIPPLE DISEASE; PATHOLOGY; PRECANCER; RADIOGRAPHY; RISK FACTOR; STROMA CELL;

AGED; BREAST; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; COHORT STUDIES; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; KERATAN SULFATE; MAMMOGRAPHY; MIDDLE AGED; PRECANCEROUS CONDITIONS; PROTEOCHONDROITIN SULFATES; PROTEOGLYCANS; RISK FACTORS; STROMAL CELLS;

EID: 0041654020     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr622     Document Type: Article

References (49)

1. V.L. Ernster J. Barclay Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: a dilemma J Natl Cancer Inst Monogr 1997 22 151 156
2. M.C. King S. Wieand K. Hale M. Lee T. Walsh K. Owens J. Tait L. Ford B.K. Dunn J. Costantino L. Wickerham N. Wolmark B. Fisher Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial JAMA 2001 286 2251 2256 1:CAS:528:DC%2BD3MXosFCktr8%3D 10.1001/jama.286.18.2251 11710890
3. W.D. Dupont D.L. Page Risk factors for breast cancer in women with proliferative breast disease N Engl J Med 1985 312 146 151 1:STN:280:DyaL2M%2Fos1Wguw%3D%3D 10.1056/NEJM198501173120303 3965932
4. D.C. Allred S.K. Mohsin S.A. Fuqua Histological and biological evolution of human premalignant breast disease Endocr Relat Cancer 2001 8 47 61 1:STN:280:DC%2BD3M3lt1Chsg%3D%3D 10.1677/erc.0.0080047 11350726
5. N.F. Boyd L.J. Martin J. Stone C. Greenberg S. Minkin M.J. Yaffe Mammographic densities as a marker of human breast cancer risk and their use in chemoprevention Curr Oncol Rep 2001 3 314 321 1:STN:280:DC%2BD3MzhvFOluw%3D%3D 10.1007/s11912-001-0083-7 11389815
6. J.J. Heine P. Malhotra Mammographic tissue, breast cancer risk, serial image analysis, and digital mammography. Part 1. Tissue and related risk factors Acad Radiol 2002 9 298 316 10.1016/S1076-6332(03)80373-2 11887946
7. N.A. Lee H. Rusinek J. Weinreb R. Chandra H. Toth C. Singer G. Newstead Fatty and fibroglandular tissue volumes in the breasts of women 20–83 years old: comparison of X-ray mammography and computer-assisted MR imaging AJR Am J Roentgenol 1997 168 501 506 1:STN:280:DyaK2s7mvVKnsA%3D%3D 10.2214/ajr.168.2.9016235 9016235
8. S. Urbanski H.M. Jensen G. Cooke D. McFarlane P. Shannon V. Kruikov N.F. Boyd The association of histological and radiological indicators of breast cancer risk Br J Cancer 1988 58 474 479 1:STN:280:DyaL1M%2Fosl2lsQ%3D%3D 10.1038/bjc.1988.244 2849977 2246805
9. N.F. Boyd H.M. Jensen G. Cooke H.L. Han Relationship between mammographic and histological risk factors for breast cancer J Natl Cancer Inst 1992 84 1170 1179 1:STN:280:DyaK38zktFersQ%3D%3D 10.1093/jnci/84.15.1170 1635085
10. N.F. Boyd H.M. Jensen G. Cooke H.L. Han G.A. Lockwood A.B. Miller Mammographic densities and the prevalence and incidence of histological types of benign breast disease. Reference Pathologists of the Canadian National Breast Screening Study Eur J Cancer Prev 2000 9 15 24 1:STN:280:DC%2BD3c3js1Oltg%3D%3D 10.1097/00008469-200002000-00003 10777006
11. C.D. Roskelley M.J. Bissell Dynamic reciprocity revisited: a continuous, bidirectional flow of information between cells and the extracellular matrix regulates mammary epithelial cell function Biochem Cell Biol 1995 73 391 397 1:CAS:528:DyaK28XptVaksw%3D%3D 10.1139/o95-046 8703411
12. S.A. Lelievre V.M. Weaver J.A. Nickerson C.A. Larabell A. Bhaumik O.W. Petersen M.J. Bissell Tissue phenotype depends on reciprocal interactions between the extracellular matrix and the structural organization of the nucleus Proc Natl Acad Sci USA 1998 95 14711 14716 1:CAS:528:DyaK1cXotVGmtL4%3D 10.1073/pnas.95.25.14711 9843954 24514
13. K. Kurose S. Hoshaw-Woodard A. Adeyinka S. Lemeshow P.H. Watson C. Eng Genetic model of multi-step breast carcinogenesis involving the epithelium and stroma: clues to tumour-microenvironment interactions Hum Mol Genet 2001 10 1907 1913 1:CAS:528:DC%2BD3MXntlSgsbw%3D 10.1093/hmg/10.18.1907 11555627
14. K. Kurose K. Gilley S. Matsumoto P.H. Watson X.P. Zhou C. Eng Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas Nat Genet 2002 32 355 357 1:CAS:528:DC%2BD38Xot1Kls7o%3D 10.1038/ng1013 12379854
15. F. Moinfar Y.G. Man L. Arnould G.L. Bratthauer M. Ratschek F.A. Tavas-soli Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis Cancer Res 2000 60 2562 2566 1:CAS:528:DC%2BD3cXjtV2qtb0%3D 10811140
16. E. Leygue L. Snell H. Dotzlaw S. Troup T. Hiller-Hitchcock L.C. Murphy P.J. Roughley P.H. Watson Lumican and decorin are differentially expressed in human breast carcinoma J Pathol 2000 192 313 320 1:CAS:528:DC%2BD3cXovVGms7c%3D 10.1002/1096-9896(200011)192:3<313::AID-PATH694>3.0.CO;2-B 11054714
17. S. Troup C. Njue E.V. Kliewer M. Parisien C. Roskelley S. Chakravarti P.J. Roughley L.C. Murphy P.H. Watson Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer Clin Cancer Res 2003 9 207 214 1:CAS:528:DC%2BD3sXnt1Oksw%3D%3D 12538471
18. S. Chakravarti T. Magnuson J.H. Lass K.J. Jepsen C. LaMantia H. Carroll Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the absence of lumican J Cell Biol 1998 141 1277 1286 1:CAS:528:DyaK1cXjs12ntbs%3D 10.1083/jcb.141.5.1277 9606218 2137175
19. R.V. Iozzo D.K. Moscatello D.J. McQuillan I. Eichstetter Decorin is a biological ligand for the epidermal growth factor receptor J Biol Chem 1999 274 4489 4492 1:CAS:528:DyaK1MXhsFSmtL4%3D 10.1074/jbc.274.8.4489 9988678
20. K.G. Danielson H. Baribault D.F. Holmes H. Graham K.E. Kadler R.V. Iozzo Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility J Cell Biol 1997 136 729 743 1:CAS:528:DyaK2sXhtFClt70%3D 10.1083/jcb.136.3.729 9024701 2134287
21. R.V. Iozzo The biology of the small leucine-rich proteoglycans. Functional network of interactive proteins J Biol Chem 1999 274 18843 18846 1:CAS:528:DyaK1MXksVWmu78%3D 10.1074/jbc.274.27.18843 10383378
22. N.F. Boyd J. Stone L.J. Martin R. Jong E. Fishell M. Yaffe G. Hammond S. Minkin The association of breast mitogens with mammographic densities Br J Cancer 2002 87 876 882 1:STN:280:DC%2BD38nhsFegsg%3D%3D 10.1038/sj.bjc.6600537 12373602 2376176
23. N.F. Boyd G.S. Dite J. Stone A. Gunasekara D.R. English M.R. McCredie G.G. Giles D. Tritchler A. Chiarelli M.J. Yaffe J.L. Hopper Heritability of mammographic density, a risk factor for breast cancer N Engl J Med 2002 347 886 894 10.1056/NEJMoa013390 12239257
24. G.A. Greendale B.A. Reboussin S. Slone C. Wasilauskas M.C. Pike G. Ursin Postmenopausal hormone therapy and change in mammographic density J Natl Cancer Inst 2003 95 30 37 1:CAS:528:DC%2BD3sXitlOnt74%3D 10.1093/jnci/95.1.30 12509398
25. N. Boyd L. Martin J. Stone L. Little S. Minkin M. Yaffe A longitudinal study of the effects of menopause on mammographic features Cancer Epidemiol Biomarkers Prev 2002 11 1048 1053 12376506
26. C.H. van Gils J.H. Hendriks R. Holland N. Karssemeijer J.D. Otten H. Straatman A.L. Verbeek Changes in mammographic breast density and concomitant changes in breast cancer risk Eur J Cancer Prev 1999 8 509 515 1:STN:280:DC%2BD3c7gs1OmtA%3D%3D 10.1097/00008469-199912000-00006 10643940
27. C. Byrne C. Schairer J. Wolfe N. Parekh M. Salane L.A. Brinton R. Hoover R. Haile Mammographic features and breast cancer risk: effects with time, age, and menopause status J Natl Cancer Inst 1995 87 1622 1629 1:STN:280:DyaK28%2Fis1aluw%3D%3D 10.1093/jnci/87.21.1622 7563205
28. C.A. Haiman S.E. Hankinson I. De Vivo C. Guillemette N. Ishibe D.J. Hunter C. Byrne Polymorphisms in steroid hormone pathway genes and mammographic density Breast Cancer Res Treat 2003 77 27 36 1:CAS:528:DC%2BD38XovVClt7g%3D 10.1023/A:1021112121782 12602902
29. J.J. Heine P. Malhotra Mammographic tissue, breast cancer risk, serial image analysis, and digital mammography. Part 2. Serial breast tissue change and related temporal influences Acad Radiol 2002 9 317 335 10.1016/S1076-6332(03)80374-4 11887947
30. J. Brisson B. Brisson G. Cote E. Maunsell S. Berube J. Robert Tamoxifen and mammographic breast densities Cancer Epidemiol Biomarkers Prev 2000 9 911 915 1:CAS:528:DC%2BD3cXntFOis78%3D 11008908
31. C.M. Friedenreich H.E. Bryant F. Alexander J. Hugh J. Danyluk D.L. Page Risk factors for benign breast biopsies: a nested case-control study in the Alberta breast screening program Cancer Detect Prev 2001 25 280 291 1:STN:280:DC%2BD3MzmsVKjtA%3D%3D 11425270
32. Y.P. Guo L.J. Martin W. Hanna D. Banerjee N. Miller E. Fishell R. Khokha N.F. Boyd Growth factors and stromal matrix proteins associated with mammographic densities Cancer Epidemiol Biomarkers Prev 2001 10 243 248 1:CAS:528:DC%2BD3MXjtVWmsbg%3D 11303594
33. C.M. Vachon T.A. Sellers R.A. Vierkant F.F. Wu K.R. Brandt Case-control study of increased mammographic breast density response to hormone replacement therapy Cancer Epidemiol Biomarkers Prev 2002 11 1382 1388 1:CAS:528:DC%2BD38XpsVyksrc%3D 12433715
34. C.A. Haiman L. Bernstein D. Berg S.A. Ingles M. Salane G. Ursin Genetic determinants of mammographic density Breast Cancer Res 2002 4 R5 10.1186/bcr434 12052257 111030
35. E. Thurfjell Breast density and the risk of breast cancer N Engl J Med 2002 347 866 10.1056/NEJMp020093 12239254
36. J.E. Arthur I.O. Ellis C. Flowers E. Roebuck C.W. Elston R.W. Blamey The relationship of 'high risk' mammographic patterns to histological risk factors for development of cancer in the human breast Br J Radiol 1990 63 845 849 1:STN:280:DyaK3M%2FntVWltQ%3D%3D 10.1259/0007-1285-63-755-845 2252976
37. R.A. Bright A.S. Morrison J. Brisson N.A. Burstein N.S. Sadowsky D.B. Kopans J.E. Meyer Relationship between mammographic and histologic features of breast tissue in women with benign biopsies Cancer 1988 61 266 271 1:STN:280:DyaL1c%2FnvFyqsg%3D%3D 10.1002/1097-0142(19880115)61:2<266::AID-CNCR2820610212>3.0.CO;2-N 3334961
38. S.A. Bartow D.R. Pathak F.A. Mettler C.R. Key M.C. Pike Breast mammographic pattern: a concatenation of confounding and breast cancer risk factors Am J Epidemiol 1995 142 813 819 1:STN:280:DyaK28%2FhslCjtg%3D%3D 7572957
39. C. Byrne C. Schairer L.A. Brinton J. Wolfe N. Parekh M. Salane C. Carter R. Hoover Effects of mammographic density and benign breast disease on breast cancer risk (United States) Cancer Causes Control 2001 12 103 110 1:STN:280:DC%2BD3M3osFyltg%3D%3D 10.1023/A:1008935821885 11246838
40. A. Lochter M.J. Bissell Involvement of extracellular matrix constituents in breast cancer Semin Cancer Biol 1995 6 165 173 1:CAS:528:DyaK2MXnsFKrurk%3D 10.1006/scbi.1995.0017 7495985
41. K.W. Kinzler B. Vogelstein Landscaping the cancer terrain Science 1998 280 1036 7 1:CAS:528:DyaK1cXjt1aqt7Y%3D 10.1126/science.280.5366.1036 9616081
42. L.I. Yoo D.C. Chung J. Yuan LKB1 – a master tumour suppressor of the small intestine and beyond Nat Rev Cancer 2002 2 529 535 1:CAS:528:DC%2BD38XkvFKltLc%3D 10.1038/nrc843 12094239
43. E. Leygue L. Snell H. Dotzlaw K. Hole T. Hiller-Hitchcock P.J. Roughley P.H. Watson L.C. Murphy Expression of lumican in human breast carcinoma Cancer Res 1998 58 1348 1352 1:CAS:528:DyaK1cXit1elu70%3D 9537227
44. M. Pollak Insulin-like growth factor physiology and cancer risk Eur J Cancer 2000 36 1224 1228 1:CAS:528:DC%2BD3cXksFCrsrs%3D 10.1016/S0959-8049(00)00102-7 10882860
45. C. Byrne G.A. Colditz W.C. Willett F.E. Speizer M. Pollak S.E. Hankinson Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density Cancer Res 2000 60 3744 3748 1:CAS:528:DC%2BD3cXlt1Gktrs%3D 10919644
46. H.R. Haase R.W. Clarkson M.J. Waters P.M. Bartold Growth factor modulation of mitogenic responses and proteoglycan synthesis by human periodontal fibroblasts J Cell Physiol 1998 174 353 361 1:CAS:528:DyaK1cXos1emtg%3D%3D 10.1002/(SICI)1097-4652(199803)174:3<353::AID-JCP9>3.0.CO;2-N 9462697
47. L.I. Melching P.J. Roughley Modulation of keratan sulfate synthesis on lumican by the action of cytokines on human articular chondrocytes Matrix Biol 1999 18 381 390 1:CAS:528:DyaK1MXmsFSrtro%3D 10.1016/S0945-053X(99)00033-5 10517185
48. P.Y. d'Avis C.R. Frazier J.R. Shapiro N.S. Fedarko Age-related changes in effects of insulin-like growth factor I on human osteoblast-like cells Biochem J 1997 324 Pt 3 753 760 10.1042/bj3240753 9210398 1218490
49. J. Luo T. Dunn C. Ewing J. Sauvageot Y. Chen J. Trent W. Isaacs Gene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysis Prostate 2002 51 189 200 1:CAS:528:DC%2BD38Xkt1Sgu74%3D 10.1002/pros.10087 11967953